BioAge Labs BIOA
NASDAQ BIOA
$7.08 -0.06 (-0.84%)
As of: Sep 30, 2026 · 3:59 PM EDT

BioAge Labs (BIOA) Gross Margin (2025 - 2026)

Updated

BioAge Labs' Gross Margin was -580.46% in Q2 2026, down 101.89 percentage points from -478.57% a year earlier and down 206.39 percentage points from the prior quarter.

Analysis

BioAge Labs (BIOA) Gross Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, BioAge Labs' Gross Margin was -486.04% through Jun 30, 2026, up 615.70 percentage points year-over-year; for FY2025, it was -449.74%.

  • Per Business Quant data, BIOA's Gross Margin in the three quarters before Q2 2026 was -374.06% (Q1 2026), -504.84% (Q4 2025) and -496.30% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 68.19%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 74.74%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 73.54%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 78.02%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 83.60%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 72.04%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 85.33%
10 BioAge Labs 326.85 Mn 326.85 Mn -14.23 Mn -580.46%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -580.46%
Mar 31, 2026 -374.06%
Dec 31, 2025 -504.84%
Sep 30, 2025 -496.30%
Jun 30, 2025 -478.57%
Mar 31, 2025 -219.02%
API Access

BioAge Labs Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=BIOA&period=max&api_key=YOUR_API_KEY